跳至主要内容
临床试验/NCT04827238
NCT04827238已完成不适用

Standardized Invasive Hemodynamics for Monitoring Acute and Long Term Valve Performance in Patients With Elevated Gradients Post Transcatheter Aortic Valve Replacement

University of British Columbia9 个研究点 分布在 2 个国家目标入组 49 人开始时间: 2021年8月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
49
试验地点
9
主要终点
Transaortic valve gradients

研究概览

简要总结

The DISCORDANCE TAVR study will determine the discordance between echocardiography-derived and invasive transaortic gradients, as determined by a consistent and reproducible technique (Standardized Invasive Hemodynamics) post-TAVR.

详细描述

Since the introduction of Doppler echocardiography, non-invasive estimation of aortic valve gradients through modification and simplification of the Bernoulli equation and derivation of the AVA, via the continuity equation, have become the primary method to assess the severity of AS.

The utility of echocardiography to successfully determine aortic valve gradients and AVA has been established in the presence of AS, and such observations have been extrapolated to prosthetic valves. However, several reports following SAVR and TAVR for both native and valve-in-valve have demonstrated significant discordance between echocardiography-derived and direct invasive measurements of aortic valve mean gradients.

The indexed AVA (iAVA) is derived from the stroke volume indexed to the BSA. The stroke volume index (SVI) divided by the Doppler velocity time integral of the continuous wave aortic valve spectral profile, is used to determine the presence of severe PPM. As such, a low iAVA may occur due to a low flow state defined by a reduced SVI (<35 ml/m2) or a reduced stroke flow rate (< 200 ml/second) and calculated by dividing the SV by the ejection time spuriously increasing the incidence of severe PPM. A low indexed effective orifice area due to a low SVI, in the absence of intrinsic PPM, has been referred to as "pseudo-severe PPM", but the impact of flow state on PPM has not been described.

Nonetheless, echocardiographic thresholds for the evaluation of prosthetic valve performance after TAVR have been widely adopted: mean-gradient > 20mmHg, severe PPM as defined by an iAVA < 0.65 cm2/m2, and AR, including paravalvular and transvalvular AR of moderate or greater severity. These criteria are suggested to indicate procedural success and predict long-term clinical outcomes (12). Practically many centers utilize an echocardiography-derived mean gradient for the follow-up of transcatheter heart valves. While the association of at least moderate paravalvular AR with mortality has been consistently demonstrated, there remains uncertainty regarding the clinical impact of severe PPM as determined by index echocardiography. Furthermore, the magnitude of discordance between echocardiography-derived and invasive aortic valve mean-gradients post TAVR is unknown and it remains unclear how to reconcile measurement discordances in clinical practice. These potential differences may have an important impact on patient management post TAVR.

The DISCORDANCE TAVR study will determine the discordance between echocardiography-derived and invasive transaortic gradients, as determined by a consistent and reproducible technique (Standardized Invasive Hemodynamics) post-TAVR.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Echocardiographic transaortic mean gradient ≥ 20mmHg OR VARC-3 criteria for ≥ moderate hemodynamic valve deterioration post TAVR on any TTE > 1 month post-TAVR
  • Consensus by the Heart Team that the patient is suitable for Standardized Invasive Hemodynamics (SIH).

排除标准

  • CT demonstrating leaflet thrombosis or hypoattenuated leaflet thickening (HALT)

结局指标

主要结局

Transaortic valve gradients

时间窗: 30 days

Transaortic valve gradients measured by echocardiography and direct invasive methods

Patient-Prosthesis Mismatch (PPM) reclassification

时间窗: 30 days

Proportion of patients with echocardiographic severe PPM reclassified as non-severe PPM using direct invasive methods

VARC-3 hemodynamic valve deterioration reclassification

时间窗: 30 days

Proportion of patients reclassified to ≤ moderate VARC-3 hemodynamic valve deterioration using direct invasive methods, including mean gradient and valve area, compared to echocardiography

Transaortic mean gradient reclassification

时间窗: 30 days

Proportion of patients reclassified to a transaortic mean gradient \< 20mmHg using direct invasive methods

次要结局

  • Total procedure time(30 days)
  • Risks of procedural complications(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Wood

Clinical Professor

University of British Columbia

研究点 (9)

Loading locations...

相似试验